# Sibutramine Versus Continuous Positive Airway Pressure (CPAP)in Obstructive Sleep Apnea (OSA) Patients

> **NCT00729963** · PHASE4 · COMPLETED · sponsor: **Laval University** · enrollment: 45 (actual)

## Conditions studied

- Obstructive Sleep Apnea
- Obesity
- Hypertension

## Interventions

- **DRUG:** Sibutramine
- **DEVICE:** CPAP

## Key facts

- **NCT ID:** NCT00729963
- **Lead sponsor:** Laval University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2007-09
- **Final completion:** 2007-09
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2013-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00729963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00729963, "Sibutramine Versus Continuous Positive Airway Pressure (CPAP)in Obstructive Sleep Apnea (OSA) Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00729963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*